Stock AEGIR AEGIRBIO AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials AegirBio AB

Equities

AEGIR

SE0014401121

Advanced Medical Equipment & Technology

Delayed Nasdaq Stockholm
Other stock markets
 14:10:55 14/05/2024 BST 		5-day change 1st Jan Change
0.515 SEK +6.63% Intraday chart for AegirBio AB +8.08% -55.98%
04-19 AegirBio Unit Begins Arbitration Proceedings vs Salofa for Breach of Contract MT
04-09 AegirBio Signs Conditional Agreement for SEK45 Million Loan With Atlas MT

Valuation

Fiscal Period: December 2020 2021 2022
Capitalization 1 223.4 989.2 42.8
Enterprise Value (EV) 1 213.7 956.6 35.37
P/E ratio -3.03 x -9.29 x -0.11 x
Yield - - -
Capitalization / Revenue - 74,477,032 x 25,088,991 x
EV / Revenue - 72,019,947 x 20,730,843 x
EV / EBITDA -3,453,176 x -13,009,764 x -456,482 x
EV / FCF -5,816,657 x -14,756,600 x -1,825,832 x
FCF Yield -0% -0% -0%
Price to Book 6.64 x 2.67 x 1.07 x
Nbr of stocks (in thousands) 10,315 17,324 21,284
Reference price 2 21.66 57.10 2.011
Announcement Date 14/06/21 30/05/22 21/07/23
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022
Net sales - - 13.28 1.706
EBITDA - -61.89 -73.53 -77.48
EBIT - -62.08 -81.52 -89.79
Operating Margin - - -613.73% -5,263.31%
Earnings before Tax (EBT) 1 -0.000248 -62.08 -92.66 -364.3
Net income 1 -0.000248 -62.08 -92.33 -362.8
Net margin - - -695.14% -21,267.88%
EPS - -7.144 -6.143 -18.90
Free Cash Flow - -36.74 -64.82 -19.37
FCF margin - - -488.05% -1,135.42%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 20/01/20 14/06/21 30/05/22 21/07/23
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022
Net Debt 1 - - - -
Net Cash position 1 0.05 9.7 32.6 7.44
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - -36.7 -64.8 -19.4
ROE (net income / shareholders' equity) - -312% -45.1% -177%
ROA (Net income/ Total Assets) - -172% -22.7% -23.8%
Assets 1 - 36.12 406.5 1,523
Book Value Per Share 2 0.1400 3.260 21.40 1.870
Cash Flow per Share 2 0.0100 0.8700 1.960 0.6900
Capex - 0.59 - 0.07
Capex / Sales - - - 3.81%
Announcement Date 20/01/20 14/06/21 30/05/22 21/07/23
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
AEGIRBIO AB Stock AegirBio AB
-55.98% 1.38M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+11.24% 225B
DANAHER CORPORATION Stock Danaher Corporation
+9.38% 186B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+13.10% 135B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+25.93% 107B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.84% 63.56B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+5.62% 51.32B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+12.94% 51.04B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+7.15% 43.3B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+5.24% 36.99B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. AEGIR Stock
  4. Financials AegirBio AB